Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.3.2.19 (
ubiquitin-protein ligase
)
799
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The proteasome recognizes its substrates via a diverse set of ubiquitin receptors, including subunits
Rpn10
/S5a and Rpn13. In addition, shuttling factors, such as Rad23, recruit substrates to the proteasome by delivering ubiquitinated proteins. Despite the increasing understanding of the factors involved in this process, the regulation of substrate delivery remains largely unexplored. Here we report that
Rpn10
is monoubiquitinated in vivo and that this modification has profound effects on proteasome function. Monoubiquitination regulates the capacity of
Rpn10
to interact with substrates by inhibiting
Rpn10
's ubiquitin-interacting motif (UIM). We show that Rsp5, a member of NEDD4
ubiquitin-protein ligase
family, and Ubp2, a deubiquitinating enzyme, control the levels of
Rpn10
monoubiquitination in vivo. Notably, monoubiquitination of
Rpn10
is decreased under stress conditions, suggesting a mechanism of control of receptor availability mediated by the Rsp5-Ubp2 system. Our results reveal an unanticipated link between monoubiquitination signal and regulation of proteasome function.
...
PMID:Monoubiquitination of RPN10 regulates substrate recruitment to the proteasome. 2054 94